Cargando…
Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation
BACKGROUND: Chronic kidney disease (CKD) involves a variety of pathological processes, and ferroptosis plays a vital role in CKD progression. Targeting ferroptosis is a promising strategy for the treatment of CKD. However, inhibitors of ferroptosis have not been used in the clinical treatment of CKD...
Autores principales: | Song, Jiayu, Wang, Hongri, Sheng, Jingyi, Zhang, Wen, Lei, Juan, Gan, Weihua, Cai, Fangfang, Yang, Yunwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612207/ https://www.ncbi.nlm.nih.gov/pubmed/37891461 http://dx.doi.org/10.1186/s10020-023-00735-1 |
Ejemplares similares
-
Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis
por: Song, Jiayu, et al.
Publicado: (2022) -
Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2
por: Yang, Yunwen, et al.
Publicado: (2021) -
Inhibition of the IRE1/JNK pathway in renal tubular epithelial cells attenuates ferroptosis in acute kidney injury
por: Liang, Yan, et al.
Publicado: (2022) -
Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway
por: Lu, Ying, et al.
Publicado: (2018) -
Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis
por: Zhang, Bo, et al.
Publicado: (2021)